Literature DB >> 15365030

Fosfomycin and rifampin disk diffusion tests for detection of Escherichia coli mutator strains.

Juan-Carlos Galán1, Marta Tato, María-Rosario Baquero, Carmen Turrientes, Fernando Baquero, José-Luis Martinez.   

Abstract

A simple method, using commercial disks to detect Escherichia coli mutator strains, is proposed. The breakpoint for detecting strains with a mutation frequency >/=5 x 10(-7) was established at >/=70 and >/=20 colonies in the inhibition zone of fosfomycin and rifampin disks, respectively, after seeding 100 microl of an overnight culture. Strains with <30 and <10 colonies in fosfomycin and rifampin inhibition zones are presumptively non-mutators.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15365030      PMCID： PMC516308          DOI： 10.1128/JCM.42.9.4310-4312.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

Review 1.  Mutation frequencies and antibiotic resistance.

Authors:  J L Martinez; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

2.  Mutator bacteria as a risk factor in treatment of infectious diseases.

Authors:  Antoine Giraud; Ivan Matic; Miroslav Radman; Michel Fons; François Taddei
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

3.  Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes.

Authors:  Keith Miller; Alexander John O'Neill; Ian Chopra
Journal:  J Antimicrob Chemother       Date:  2002-06       Impact factor: 5.790

Review 4.  The role of mutators in the emergence of antibiotic-resistant bacteria.

Authors:  Ian Chopra; Alexander J O'Neill; Keith Miller
Journal:  Drug Resist Updat       Date:  2003-06       Impact factor: 18.500

5.  Hypermutation as a factor contributing to the acquisition of antimicrobial resistance.

Authors:  Jesús Blázquez
Journal:  Clin Infect Dis       Date:  2003-09-30       Impact factor: 9.079

6.  High frequency of mutator strains among human uropathogenic Escherichia coli isolates.

Authors:  Erick Denamur; Stéphane Bonacorsi; Antoine Giraud; Patrick Duriez; Farida Hilali; Christine Amorin; Edouard Bingen; Antoine Andremont; Bertrand Picard; François Taddei; Ivan Matic
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

7.  High mutation frequencies among Escherichia coli and Salmonella pathogens.

Authors:  J E LeClerc; B Li; W L Payne; T A Cebula
Journal:  Science       Date:  1996-11-15       Impact factor: 47.728

8.  High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

Authors:  A Oliver; R Cantón; P Campo; F Baquero; J Blázquez
Journal:  Science       Date:  2000-05-19       Impact factor: 47.728

9.  Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections.

Authors:  Patricia Komp Lindgren; Asa Karlsson; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191
  9 in total
  7 in total

1.  Detection of hypermutable Escherichia coli strains in a collection of clinical isolates by the fosfomycin-rifampin disk method.

Authors:  M Carmen Conejo; Gema Amblar; Alvaro Pascual; Evelio J Perea; Luis Martínez-Martínez
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

2.  Long-term dissemination of CTX-M-5-producing hypermutable Salmonella enterica serovar typhimurium sequence type 328 strains in Russia, Belarus, and Kazakhstan.

Authors:  Varvara K Kozyreva; Elena N Ilina; Maja V Malakhova; Alessandra Carattoli; Ilya S Azizov; Dmitry V Tapalski; Roman S Kozlov; Mikhail V Edelstein
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

3.  Spatiotemporal microbial evolution on antibiotic landscapes.

Authors:  Michael Baym; Tami D Lieberman; Eric D Kelsic; Remy Chait; Rotem Gross; Idan Yelin; Roy Kishony
Journal:  Science       Date:  2016-09-09       Impact factor: 47.728

4.  Assessment of the Potential for Inducing Resistance in Multidrug-Resistant Organisms from Exposure to Minocycline, Rifampin, and Chlorhexidine Used To Treat Intravascular Devices.

Authors:  Joel Rosenblatt; Nylev Vargas-Cruz; Ruth A Reitzel; Issam I Raad
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

5.  Convergent in vivo and in vitro selection of ceftazidime resistance mutations at position 167 of CTX-M-3 beta-lactamase in hypermutable Escherichia coli strains.

Authors:  Marina N Stepanova; Maxim Pimkin; Anatoly A Nikulin; Varvara K Kozyreva; Elena D Agapova; Mikhail V Edelstein
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

6.  Indigenous and environmental modulation of frequencies of mutation in Lactobacillus plantarum.

Authors:  Ronnie Machielsen; Ingrid J van Alen-Boerrigter; Lucy A Koole; Roger S Bongers; Michiel Kleerebezem; Johan E T Van Hylckama Vlieg
Journal:  Appl Environ Microbiol       Date:  2009-12-28       Impact factor: 4.792

7.  Quality and safety requirements for sustainable phage therapy products.

Authors:  Jean-Paul Pirnay; Bob G Blasdel; Laurent Bretaudeau; Angus Buckling; Nina Chanishvili; Jason R Clark; Sofia Corte-Real; Laurent Debarbieux; Alain Dublanchet; Daniel De Vos; Jérôme Gabard; Miguel Garcia; Marina Goderdzishvili; Andrzej Górski; John Hardcastle; Isabelle Huys; Elizabeth Kutter; Rob Lavigne; Maia Merabishvili; Ewa Olchawa; Kaarle J Parikka; Olivier Patey; Flavie Pouilot; Gregory Resch; Christine Rohde; Jacques Scheres; Mikael Skurnik; Mario Vaneechoutte; Luc Van Parys; Gilbert Verbeken; Martin Zizi; Guy Van den Eede
Journal:  Pharm Res       Date:  2015-01-14       Impact factor: 4.200
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.